KASL clinical practice guidelines: management of alcoholic liver disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyung Joon | - |
dc.date.accessioned | 2021-09-16T04:40:24Z | - |
dc.date.available | 2021-09-16T04:40:24Z | - |
dc.date.issued | 2013-09 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/49187 | - |
dc.description.abstract | [No abstract available] | - |
dc.format.extent | 39 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | KASL clinical practice guidelines: management of alcoholic liver disease | - |
dc.type | Article | - |
dc.identifier.doi | 10.3350/cmh.2013.19.3.216 | - |
dc.identifier.bibliographicCitation | Clinical and molecular hepatology, v.19, no.3, pp 216 - 254 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84899040958 | - |
dc.citation.endPage | 254 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 216 | - |
dc.citation.title | Clinical and molecular hepatology | - |
dc.citation.volume | 19 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Alcoholic liver disease | - |
dc.subject.keywordAuthor | Practice guidelines | - |
dc.subject.keywordPlus | baclofen | - |
dc.subject.keywordPlus | disulfiram | - |
dc.subject.keywordPlus | naltrexone | - |
dc.subject.keywordPlus | alcohol abstinence | - |
dc.subject.keywordPlus | alcohol liver disease | - |
dc.subject.keywordPlus | Alcohol-Related Disorders | - |
dc.subject.keywordPlus | alcoholic fatty liver | - |
dc.subject.keywordPlus | drinking behavior | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | liver cirrhosis | - |
dc.subject.keywordPlus | Liver Diseases, Alcoholic | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | pathophysiology | - |
dc.subject.keywordPlus | practice guideline | - |
dc.subject.keywordPlus | prevalence | - |
dc.subject.keywordPlus | prognosis | - |
dc.subject.keywordPlus | psychology | - |
dc.subject.keywordPlus | questionnaire | - |
dc.subject.keywordPlus | risk factor | - |
dc.subject.keywordPlus | severity of illness index | - |
dc.subject.keywordPlus | Alcohol Abstinence | - |
dc.subject.keywordPlus | Alcohol Drinking | - |
dc.subject.keywordPlus | Alcohol-Related Disorders | - |
dc.subject.keywordPlus | Baclofen | - |
dc.subject.keywordPlus | Disulfiram | - |
dc.subject.keywordPlus | Fatty Liver, Alcoholic | - |
dc.subject.keywordPlus | Hepatitis, Alcoholic | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Liver Cirrhosis | - |
dc.subject.keywordPlus | Liver Diseases, Alcoholic | - |
dc.subject.keywordPlus | Naltrexone | - |
dc.subject.keywordPlus | Prevalence | - |
dc.subject.keywordPlus | Prognosis | - |
dc.subject.keywordPlus | Risk Factors | - |
dc.subject.keywordPlus | Severity of Illness Index | - |
dc.subject.keywordPlus | Surveys and Questionnaires | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.